Tygh Capital Management, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$4,278,000
+6.9%
64,518
+0.6%
0.55%
+0.9%
Q3 2021$4,003,000
-23.6%
64,127
+1.4%
0.54%
-24.1%
Q2 2021$5,240,000
+23.6%
63,269
-1.1%
0.71%
+19.2%
Q1 2021$4,240,000
-36.1%
63,947
-26.1%
0.60%
-42.0%
Q4 2020$6,638,000
+176.6%
86,512
+55.2%
1.03%
+127.0%
Q3 2020$2,400,00055,7260.46%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders